Immunovia is a startup based in Sweden, most recent round Series-c-plus, 1 tracked investor.
Immunovia is a startup founded in 2007 based in Sweden. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Immunovia AB develops and commercializes blood-based diagnostic tests for early detection of pancreatic cancer, focusing on identifying proteins and antibodies indicating cancer in high-risk individuals.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.